Atlas Trials

Assessment of the Impact of Gadolinium Injection on the Measurement of the QSM Signal

Clinical trial NCT04906941 · COMPLETED

Trial details

NCT number
NCT04906941
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Status
COMPLETED
Study type
OBSERVATIONAL
White Matter Disease
Start date
2022-01-21
Primary completion
2023-07-19
Enrollment
73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.